Kerr Douglas's most recent trade in Dyne Therapeutics Inc was a trade of 904 Common Stock done at an average price of $14.9 . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.90 per share. | 05 Mar 2026 | 904 | 171,606 | - | 14.9 | 13,470 | Common Stock |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 130,000 | 130,000 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 85,000 | 172,510 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.72 per share. | 05 Dec 2025 | 880 | 87,510 | - | 20.7 | 18,234 | Common Stock |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.27 per share. | 04 Sep 2025 | 3,552 | 89,263 | - | 13.3 | 47,135 | Common Stock |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 04 Sep 2025 | 873 | 88,390 | - | 13.4 | 11,707 | Common Stock |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 65,110 | 65,110 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.35 per share. | 05 Jun 2025 | 1,342 | 92,815 | - | 13.4 | 17,916 | Common Stock |
| Dyne Therapeutics Inc | Douglas Kerr | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 05 Mar 2025 | 1,343 | 94,157 | - | 11.8 | 15,888 | Common Stock |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 5,021 | 0 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 5,021 | 387,104 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.90 per share. | 29 Jan 2024 | 1,476 | 385,628 | - | 1.9 | 2,804 | Common Stock |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 7,437 | 380,286 | - | - | Common Stock | |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 7,437 | 7,437 | - | - | Restricted Stock Units | |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 6,694 | 20,081 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 6,694 | 384,403 | - | - | Common Stock | |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 2,577 | 377,709 | - | 1.9 | 4,922 | Common Stock |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 2,320 | 382,083 | - | 1.9 | 4,431 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 7,437 | 367,333 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 7,437 | 14,874 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 15 Jul 2023 | 2,183 | 365,150 | - | 5.1 | 11,090 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 7,437 | 358,963 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 7,437 | 22,311 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 15 Apr 2023 | 2,183 | 356,780 | - | 4.5 | 9,824 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 53,550 | 53,550 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 26,775 | 26,775 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 7,438 | 29,748 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 7,438 | 354,104 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. | 15 Jan 2023 | 2,578 | 351,526 | - | 5.1 | 13,148 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 7,438 | 37,186 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 7,438 | 346,985 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. | 15 Oct 2022 | 2,184 | 344,801 | - | 5.6 | 12,252 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 14,876 | 343,914 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 14,876 | 44,624 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 15 Jul 2022 | 4,367 | 339,547 | - | 7.2 | 31,355 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 119,000 | 119,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 59,500 | 59,500 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2021 | 3,518 | 38,699 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 08 Jul 2021 | 3,518 | 330,076 | - | 5.2 | 18,153 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.39 per share. | 08 Jul 2021 | 1,889 | 326,558 | - | 25.4 | 47,962 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.99 per share. | 08 Jul 2021 | 1,629 | 328,447 | - | 25.0 | 40,709 | Common Stock |